These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 28253985)
41. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease. Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290 [TBL] [Abstract][Full Text] [Related]
42. Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Caldwell CC; Yao J; Brinton RD Neurotherapeutics; 2015 Jan; 12(1):66-80. PubMed ID: 25534394 [TBL] [Abstract][Full Text] [Related]
43. [Alzheimer's disease: new prospects in therapy and applied experimental models]. Kubis AM; Janusz M Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208 [TBL] [Abstract][Full Text] [Related]
44. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease. Jeong S Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263 [TBL] [Abstract][Full Text] [Related]
45. Role of mitochondrial amyloid-beta in Alzheimer's disease. Chen JX; Yan SS J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403 [TBL] [Abstract][Full Text] [Related]
46. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease. Eckert A; Nisbet R; Grimm A; Götz J Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203 [TBL] [Abstract][Full Text] [Related]
47. Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons. He Y; Jia K; Li L; Wang Q; Zhang S; Du J; Du H Biochem Biophys Res Commun; 2018 Apr; 498(4):1066-1072. PubMed ID: 29551684 [TBL] [Abstract][Full Text] [Related]
54. Advances in developing novel therapeutic strategies for Alzheimer's disease. Cao J; Hou J; Ping J; Cai D Mol Neurodegener; 2018 Dec; 13(1):64. PubMed ID: 30541602 [TBL] [Abstract][Full Text] [Related]
55. Mitochondrial therapeutic interventions in Alzheimer's disease. Van Giau V; An SSA; Hulme JP J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965 [TBL] [Abstract][Full Text] [Related]
56. Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease? Su B; Wang X; Bonda D; Perry G; Smith M; Zhu X Mol Neurobiol; 2010 Jun; 41(2-3):87-96. PubMed ID: 20101529 [TBL] [Abstract][Full Text] [Related]
57. Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. Lanzillotta C; Di Domenico F; Perluigi M; Butterfield DA CNS Drugs; 2019 Oct; 33(10):957-969. PubMed ID: 31410665 [TBL] [Abstract][Full Text] [Related]
58. Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy. Li L; Zhang L; Yang CC Curr Top Med Chem; 2016; 16(5):537-48. PubMed ID: 26268330 [TBL] [Abstract][Full Text] [Related]
59. Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment. Yao J; Brinton RD Curr Pharm Des; 2011; 17(31):3474-9. PubMed ID: 21902662 [TBL] [Abstract][Full Text] [Related]
60. Subcellular injuries in Alzheimer's disease. Tillement JP; Papadopoulos V CNS Neurol Disord Drug Targets; 2014; 13(4):593-605. PubMed ID: 24168366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]